Orexigen Beats the Odds, Wins OK from FDA Panel for Obesity Drug

Orexigen Therapeutics, the San Diego-based developer of obesity drugs, beat the odds today by winning a positive recommendation from an FDA advisory panel that said its lead drug deserves a spot on the US market.